FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1234931005: Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5084760010 Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5084762019 Aluminum hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxethazaine 2 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5348060010 Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension Has manufactured dose form Oral suspension true Inferred relationship Some
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension Plays role Laxative therapeutic role false Inferred relationship Some
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Oxetacaine true Inferred relationship Some 1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Oxetacaine true Inferred relationship Some 1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 1
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Aluminium hydroxide true Inferred relationship Some 2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Aluminium hydroxide true Inferred relationship Some 2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 2
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Magnesium hydroxide (substance) true Inferred relationship Some 3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Magnesium hydroxide (substance) true Inferred relationship Some 3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 3
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension Is a Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start